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Abstract
Background: Species of the genus Acinetobacter are Gram-negative and highly drug-resistant bacilli that normally
reside on the skin, oropharynx, and perineum. Several previous studies have reported prosthetic valve endocarditis
due to A. baumannii infection.
Case presentation: Here we present a case of late endocarditis of a bioprosthetic tricuspid valve due to A.
baumannii complex in a patient who had surgical replacement with a bioprosthetic tricuspid valve six years previously.
Conclusions: We completed tricuspid valve replacement using a 29 mm St. June mechanical prosthetic valve for the
patient. Postoperatively, she received intravenous cefoperazone sodium and sulbactam sodium for 2 months and had
good recovery.
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Background
Tricuspid valve infective endocarditis is an infrequent
diagnosis, accounting for only 5 to 10 % of all cases of
infective endocarditis, and is most common in intraven-
ous drug users [1, 2]. Prosthetic valve endocarditis is a
serious condition because it can result in death. Late
prosthetic infection resembles other forms of infective
endocarditis, both clinically and bacteriologically [3].
Here, we report a case of late infective bioprosthetic
tricuspid valve endocarditis caused by Acinetobacter
baumannii, with large vegetations and damage of the
artificial valve. Although medical therapy was effective, re-
placement with a new mechanical tricuspid valve allowed
the patient to achieve satisfactory recovery.
Case presentation
A 56-year-old female was admitted to our hospital with a
fever, double lower extremity edema, and recent weight
loss. Eleven years ago, she had a mitral valve replacement
with a 27 mm St. Jude mechanical valve, and six years
ago she had a bioprosthetic tricuspid valve replace-
ment with a 29 mm Edwards bioprosthetic valve due to
severe tricuspid valve regurgitation. Since earlier this year,
she had recurrent abdominal distension and double lower
extremity edema, symptoms that were alleviated by treat-
ment with a diuretic. She first presented to a local hospital
in January with complaints of fever and cough for the
previous month. A chest X-ray at that time indicated
pulmonary infection, and transthoracic echocardiography
showed bioprosthetic tricuspid valve calcification and
medium regurgitation, but no vegetation. She was pre-
scribed oral antibiotics and diuretics for two months.
Despite decreased coughing and evidence of improvement
in her chest X-ray films, she continued to suffer from
abdominal distension and double lower extremity edema.
Three different blood cultures were negative, and she was
admitted to our hospital in Iune. The patient had no
history of intravenous drug abuse or diabetes mellitus.
Her body weight had declined by 10 kg since this year.
On admission to our unit, she had a temperature of
37 °C, atrial fibrillation with an average rate of 70 beats/
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min, and blood pressure of 120/60 mmHg. Auscultation
indicated a diastolic sound below the xiphoid process.
Laboratory tests showed leukocytosis (15.5 × 109 WBCs/L)
and anemia (75 g Hb/L). Her serum level of C-reactive
protein was 15 mg/dL, erythrocyte sedimentation rate was
25 mm/h, and a chest X-ray film demonstrated scattered
patches in both lower lung fields. The patient’s status
began to deteriorate on the second day after admission.
She suffered from intermittent whole-body chills and a
fever spiking up to 39 °C. Transthoracic echocardiography
showed large vegetations attached to the bioprosthetic
tricuspid valve, damage to two of the three leaves, and
severe tricuspid regurgitation. Blood cultures were pre-
pared from three samples collected at hourly intervals,
and led to a diagnosis of A. baumannii of the biopros-
thetic tricuspid valve. Antimicrobial susceptibility testing
showed that the isolate was sensitive to cefoperazone
sodium and sulbactam sodium, but resistant to imipenem,
penicillin, ampicillin, clindamycin, and linezolid. Thus, we
initiated treatment with intravenous cefoperazone sodium
and sulbactam sodium. After 4 weeks of antibiotic therapy,
her pyrexia was completely controlled and intermittent
blood cultures showed negative results. We therefore
performed re-tricuspid valve replacement.
We completed valve replacement in the beating heart
under cardiopulmonary bypass, during which we noted
vegetations on all 3 leaves and damage to 2 of the leaves
(Figs. 1 and 2). We used a dilute iodine solution in normal
saline- cefoperazone sodium to irrigate the surface of the
tricuspid annulus after removal of the bioprosthetic valve.
A 29 mm St. June mechanical prosthetic valve was
inserted according to the patient’s choice. Intraoperative
cultures of the vegetations were negative. Postoperatively,
she received intravenous cefoperazone sodium and sulbac-
tam sodium for 2 months. Before discharge, all post-
operative numerous blood cultures showed negative re-
sults and the patient reported that cardiac insufficiency-
related symptoms were significantly ameliorated. During
the follow-up period, there was no fever, no symp-
toms of infection, and no cardiac insufficiency.
A. baumannii was initially thought to be an organism of
questionable pathogenicity, but has emerged as a major
cause of nosocomial infections. Isolates of this species are
frequently resistant to multiple antimicrobial agents, and
can therefore cause life-threatening infections in suscep-
tible patients [4–6]. Invasive medical procedures and use
of broad-spectrum antibiotics increase the risk for A.
baumannii infection. Consequently, episodes of A. bau-
mannii bacteremia occur most frequently in patients
admitted to intensive care units. Other reports indicate
that the most common pathogens responsible for pros-
thetic valve endocarditis are of nosocomial origin, such as
coagulase-negative staphylococci, Staphylococcus aureus,
or Gram-negative bacilli [7]. Prosthetic valve endocarditis
due to Acinetobacter is rare, and the present case of late
bioprosthetic prosthetic valve endocarditis by A. bauman-
nii is very unusual.
Olut and colleagues presented a case of early prosthetic
valve endocarditis due to A. baumannii that was accom-
panied by a cutaneous eruption. In this case, a 6–7 mm
vegetation was present on the aortic valve. Although
appropriate antibiotics were started immediately, the pa-
tient died of septic shock and disseminated intravascular
coagulation [8]. Menon and colleagues reported a case of
Fig. 1 The damaged bioprosthetic tricuspid valve with vegetations
Fig. 2 The damaged bioprosthetic tricuspid valve with vegetations
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infective endocarditis caused by A. baumannii complex in
a 27-year-old male who underwent surgical repair of a
ruptured aneurysm of the sinus of Valsalva one month
previously. This patient died of sepsis before appropriate
antibiotic therapy could be started [9]. Kumar et al.
reported a 23-year-old female who underwent surgical
replacement of the mitral valve and developed late
endocarditis of the mechanical prosthetic valve due to A.
baumannii complex. This patient, who received surgical
replacement with a Starr-Edwards mechanical prosthetic
valve 5 years previously, was treated with ofloxacin and
amikacin and was soon afebrile [10]. Gradon et al.
reported community-acquired infective endocarditis of a
native valve that was caused by A. calcoaceticus subspecies
anitratus. They further reported that 5 of 15 previously
described patients with native valve endocarditis and 1 of
6 with prosthetic valve endocarditis died. These authors
recommended therapy with antimicrobial agents known
to be active against Acinetobacter [11].
In our patient, bioprosthetic tricuspid valve endocarditis
developed six years after surgery, similar to the patient re-
ported by Kumar et al. Although our patient’s symptoms
and signs of cardiac insufficiency were initially misinter-
preted, diagnosis was firmly established following isolation
of A. baumannii from blood cultures. After admission,
transthoracic echocardiography confirmed the presence of
large vegetations attached to bioprosthetic tricuspid valve,
which were not noted in her initial visit to a local hospital.
Generally, imipenem is active against A. baumannii, but
this species has developed resistance to multiple anti-
microbial agents, such as imipenem, penicillin, ampicillin,
clindamycin, and linezolid. Fortunately, the usual treat-
ment for this patient is an active β-lactam alone, prefera-
bly one with a limited spectrum. Thus, we administered
intravenous cefoperazone sodium and sulbactam sodium
for about two months, a treatment that was successful.
The choice of the type of tricuspid prosthesis remains
a matter of debate. In our patient’s second operation, a
biological prosthetic valve was used in anticipation that
this valve would have a slower degenerative evolution
for the lower pressure stress in the right heart and was
less likely to cause a thrombotic event [12–14]. There is
no evidence that biological prosthetic valves are more
likely to cause endocarditis. However, based on echocardi-
ography, large vegetations were attached to the biological
prosthetic tricuspid valve that damaged the biological
leaves and led to severe tricuspid regurgitation. This
necessitated surgery and valve replacement and the pa-
tient chose a mechanical valve for this third operation.
Similar to many other reports on the outcomes following
surgery for tricuspid valve infective endocarditis, we ob-
tained a favorable result [15, 16]. Following surgery and
intravenous antibiotic therapy, the patient’s symptoms of
cardiac insufficiency had resolved.
Conclusions
In conclusion, this case highlights a rare case of late
infective endocarditis of a bioprosthetic tricuspid valve
due to A. baumannii that was resistant to multiple antibi-
otics. Surgical replacement with a mechanical prosthetic
valve accompanied by appropriate antibiotic treatment
was successful.
Written informed consent was obtained from the pa-
tient for publication of this case report and any accom-
panying images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
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